Author: Sydney Shepherd
-
Lighting the Way an to Alzheimer’s Cure: The Future of Optogenetics in Disease Treatment
Alzheimer’s is one of the most prevalent and devastating neurodegenerative diseases globally, and affects approximately 35.8% of people over the age of 85 (Alzheimer’s Association 2026). Alzheimer’s disease is primarily attributed to the buildup of amyloid-beta (Aβ) peptides (plaque) within the brain parenchyma, which occurs when non-functional microglia and astrocytes, both types of glial cells,…